Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma
Clinical trial NCT03821363 · UNKNOWN
Trial details
- NCT number
- NCT03821363
- Sponsor
- Sinocelltech Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-13
- Primary completion
- 2020-07-01
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.